BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18988557)

  • 1. Coming soon to your lab: NAF for breast-cancer risk assessment.
    Bentz J
    MLO Med Lab Obs; 2008 Oct; 40(10):52-3. PubMed ID: 18988557
    [No Abstract]   [Full Text] [Related]  

  • 2. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
    Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
    Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
    Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal lavage in the screening of high-risk women.
    Kenney PJ; Ellison MC
    Curr Womens Health Rep; 2003 Apr; 3(2):151-5. PubMed ID: 12628085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient variables that predict atypical cytology by nipple duct lavage.
    Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
    Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
    Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
    Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal lavage and its histopathologic basis: a cautionary tale.
    Badve S
    Diagn Cytopathol; 2004 Mar; 30(3):166-71. PubMed ID: 14986296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of nipple fluid for breast cancer screening.
    Suijkerbuijk KP; van der Wall E; Vooijs M; van Diest PJ
    Pathobiology; 2008; 75(2):149-52. PubMed ID: 18544970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytodiagnosis of breast neoplasms using nipple discharge].
    Matsuda M
    Rinsho Byori; 1985 Jul; Spec No 64():35-58. PubMed ID: 3906184
    [No Abstract]   [Full Text] [Related]  

  • 11. Nipple aspirate cytology for the study of breast cancer precursors.
    King EB; Chew KL; Petrakis NL; Ernster VL
    J Natl Cancer Inst; 1983 Dec; 71(6):1115-21. PubMed ID: 6581355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: ductal lavage of the breast.
    Linder J
    Diagn Cytopathol; 2004 Mar; 30(3):140-2. PubMed ID: 14986292
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry.
    He J; Gornbein J; Shen D; Lu M; Rovai LE; Shau H; Katz J; Whitelegge JP; Faull KF; Chang HR
    Int J Oncol; 2007 Jan; 30(1):145-54. PubMed ID: 17143523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal lavage and risk assessment of breast cancer.
    Arun B
    Oncologist; 2004; 9(6):599-605. PubMed ID: 15561804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal lavage: clinical utility and future promise.
    O'Shaughnessy JA
    Surg Clin North Am; 2003 Aug; 83(4):753-69, vii. PubMed ID: 12875594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-tissue sampling for risk assessment and prevention.
    Fabian CJ; Kimler BF; Mayo MS; Khan SA
    Endocr Relat Cancer; 2005 Jun; 12(2):185-213. PubMed ID: 15947097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nipple-aspirate fluid cytology in breast-cancer risk screening.
    Bentz J
    MLO Med Lab Obs; 2009 Mar; 41(3):8, 10, 12-7. PubMed ID: 19374177
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of 2,6-cyclolycopene-1,5-diol in breast nipple aspirate fluids and plasma: a potential marker of oxidative stress.
    Chen G; Djuric Z
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1592-6. PubMed ID: 12496049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of breast ductoscopy in breast cancer screening.
    Sarakbi WA; Escobar PF; Mokbel K
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):208-11. PubMed ID: 16468470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nipple fluid cytology.
    Masood S; Khalbuss WE
    Clin Lab Med; 2005 Dec; 25(4):787-94, vii-viii. PubMed ID: 16308092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.